(a) Notwithstanding any other state law other than Sections 549.0152 and 549.0153, information the commission obtains or maintains regarding prescription drug rebate negotiations or a supplemental Medicaid or other rebate agreement, including trade secrets, rebate amount, rebate percentage, and manufacturer or labeler pricing, is confidential and not subject to disclosure under Chapter 552.
(b) Information that is confidential under Subsection (a) includes information described by that subsection that the commission obtains or maintains in connection with:
(1) the vendor drug program;
(2) the child health plan program;
(3) the kidney health care program;
(4) the children with special health care needs program; or
(5) another state program the commission or a health and human services agency administers.

Text of section effective on April 01, 2025